HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias - Poll - MDSpire

HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias

  • By

  • Rony Mshaik

  • John Simonet

  • Aleksandra Georgievski

  • Layla Jamal

  • Shaliha Bechoua

  • Paola Ballerini

  • Pierre-Simon Bellaye

  • Zandile Mlamla

  • Jean-Paul Pais de Barros

  • Audrey Geissler

  • Pierre-Jean Francin

  • François Girodon

  • Carmen Garrido

  • Ronan Quéré

  • March 18, 2021

  • 0 min

Share

Original Source(s)

HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias

  • by Rony Mshaik, John Simonet, Aleksandra Georgievski, Layla Jamal, Shaliha Bechoua, Paola Ballerini, Pierre-Simon Bellaye, Zandile Mlamla, Jean-Paul Pais de Barros, Audrey Geissler, Pierre-Jean Francin, François Girodon, Carmen Garrido, Ronan Quéré

  • March 18, 2021

Related Content

Professor LU Daopei: Chinese Transplant Pioneer, 30 October, 1931–2 April, 2025

Impact of center volume on outcomes in allogeneic hematopoietic cell transplantation for children

Early mortality after chemotherapy as a quality indicator—the leukemia perspective